You have 8 free searches left this month | for more free features.

Tumor Treating Fields

Showing 51 - 75 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Prostate Cancer Trial in Canada, United States (70.2 Gy 3D-CRT/IMRT, 79.2 Gy 3D-CRT/IMRT)

Completed
  • Prostate Cancer
  • 70.2 Gy 3D-CRT/IMRT
  • 79.2 Gy 3D-CRT/IMRT
  • Long Beach, California
  • +85 more
Dec 27, 2022

Head Neck Cancer, Head and Neck Squamous Cell Carcinoma, Oropharynx Cancer Trial in United States (other, radiation, diagnostic

Not yet recruiting
  • Head and Neck Cancer
  • +4 more
  • Experimental Observation
  • +3 more
  • Baltimore, Maryland
  • +5 more
Oct 16, 2023

Breast Cancer Trial in Sittard (Pintuition)

Active, not recruiting
  • Breast Cancer
  • Pintuition
  • Sittard, Limburg, Netherlands
    Zuyderland Medical Center
Sep 19, 2023

FDG-PET/CT for Simulation and Radiation Treatment Planning of

Active, not recruiting
  • Breast Neoplasm
    • Geneva, Switzerland
      Radiation oncology, Geneva University Hospitals
    Dec 18, 2022

    Collection of Tissue Samples for Cancer Research

    Recruiting
    • Neoplasms
    • +3 more
    • Biopsy
    • Atlanta, Georgia
    • +9 more
    Jan 23, 2023

    Glioma, High Grade Glioma, Glioma, Malignant Trial in Philadelphia (18F-Fluciclovine PET-MRI)

    Recruiting
    • Glioma
    • +4 more
    • 18F-Fluciclovine PET-MRI
    • Philadelphia, Pennsylvania
      Children's Hospital of Philadelphia
    Dec 22, 2022

    And Immuno-meDIated Adverse Events in Anti-cancer

    Not yet recruiting
    • Cancer
      • (no location specified)
      Jun 26, 2023

      Prostatic Tumor Trial in Amsterdam, Utrecht (177Lu-PSMA-617, EBRT)

      Recruiting
      • Prostatic Neoplasm
      • Amsterdam, Netherlands
      • +1 more
      Dec 21, 2021

      Breast Cancer Metastatic, Leptomeningeal Metastasis Trial (Tucatinib Oral Tablet, Capecitabine tablets, Trastuzumab Injection)

      Not yet recruiting
      • Breast Cancer Metastatic
      • Leptomeningeal Metastasis
      • Tucatinib Oral Tablet
      • +2 more
      • (no location specified)
      Mar 23, 2023

      NSCLC Trial (Metastatic vertebrae treated with SBRT)

      Not yet recruiting
      • NSCLC
      • Metastatic vertebrae treated with SBRT
      • (no location specified)
      Oct 8, 2022

      Lung Cancer, Esophageal Cancer, Mesothelioma; Lung Trial (LCR Meter (Brand: Keysight, Serial Number:E498AL))

      Not yet recruiting
      • Lung Cancer
      • +2 more
      • LCR Meter (Brand: Keysight, Serial Number:E498AL)
      • (no location specified)
      Mar 15, 2021

      3D Specimen Maps for RT Planning

      Recruiting
      • Head and Neck Cancer
      • +2 more
        • Nashville, Tennessee
          Vanderbilt Medical Center
        Feb 23, 2023

        High Grade Glioma, Ependymoma Trial in Orlando, Hackensack (Optune NovoTTF-200A System)

        Recruiting
        • High Grade Glioma
        • Ependymoma
        • Optune NovoTTF-200A System
        • Orlando, Florida
        • +1 more
        Aug 12, 2022

        Clinically Nonfunctioning Pituitary Adenomas

        Recruiting
        • Pituitary Adenoma
        • Pituitary Tumor
        • Surgical intervention for CNFA
        • Radiotherapy for CNFA
        • New York, New York
          Columbia University Vagelos College of Physicians & Surgeons
        Oct 24, 2022

        Wilms Tumor Trial in Memphis (device, drug, procedure)

        Recruiting
        • Wilms Tumor
        • Proton Beam Radiation (PBRT)
        • +4 more
        • Memphis, Tennessee
          St.Jude Children's Research Hospital
        Sep 1, 2021

        Glioblastoma Multiforme Trial in Brooklyn

        Recruiting
        • Glioblastoma Multiforme
          • Brooklyn, New York
            New York Presbyterian - Brooklyn Methodist Hospital
          Dec 14, 2018

          NSCLC Stage I Trial in Baltimore (Post-SABR Biopsy)

          Recruiting
          • Non-small Cell Lung Cancer Stage I
          • Post-SABR Biopsy
          • Baltimore, Maryland
            Bayview Medical Center
          Nov 23, 2021

          TTFields In GErmany in Routine Clinical Care

          Unknown status
          • Glioblastoma
          • TTFields
          • Aschaffenburg, Bavaria, Germany
            Clinical center Aschaffenburg-Alzenau
          Jan 27, 2021

          Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma Trial

          Not yet recruiting
          • Advanced Esophageal Adenocarcinoma
          • +14 more
          • (no location specified)
          Jan 3, 2023

          Circulating Tumor DNA for Early Treatment Response Assessment of

          Recruiting
          • Healthy Volunteer
          • +12 more
            • Saint Louis, Missouri
              Washington University School of Medicine
            Apr 4, 2022

            Glioma, Glioblastoma Trial in United States (drug, radiation, procedure)

            Recruiting
            • Glioma
            • Glioblastoma
            • Phoenix, Arizona
            • +3 more
            Oct 13, 2022

            Advanced Melanoma, Metastatic Melanoma Trial in Saint Louis (Memory-like natural killer cells, Relatilmab, Nivolumab)

            Not yet recruiting
            • Advanced Melanoma
            • Metastatic Melanoma
            • Memory-like natural killer cells
            • +2 more
            • Saint Louis, Missouri
              Washington University School of Medicine
            Nov 16, 2022

            Neuroendocrine Tumors Trial (Lutathera)

            Not yet recruiting
            • Neuroendocrine Tumors
            • (no location specified)
            Aug 23, 2022

            Venous Leg Ulcer Trial in Karachi (PRP, Conventional therapy)

            Completed
            • Venous Leg Ulcer
            • PRP
            • Conventional therapy
            • Karachi, Sindh, Pakistan
              Jinnah Post graduate Medical centre
            Aug 2, 2023

            Glioblastoma, IDH-wildtype Trial in Beijing (Elemene, Placebo)

            Not yet recruiting
            • Glioblastoma, IDH-wildtype
            • Beijing, China
              Peking Union Medical College Hospital
            Apr 22, 2023